Kazia Therapeutics Limited (KZIA)

NASDAQ: KZIA · IEX Real-Time Price · USD

0.214

-0.003 (-1.15%)

At close: Jul 2, 2024, 4:00 PM

0.223

+0.009 (3.97%)

After-hours: Jul 2, 2024, 6:19 PM EDT

Kazia Therapeutics Cash Flow Statement

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Year	2023	2022	2021	2020	2019	2018 - 2000
Net Income	-20.47	-25.01	-8.42	-12.47	-10.27	Upgrade
Depreciation & Amortization	1.87	1.87	1.27	1.08	1.08	Upgrade
Share-Based Compensation	1.16	1.68	0.64	0.26	0.25	Upgrade
Other Operating Activities	2.28	-1.29	-2.59	2.31	2.23	Upgrade
Operating Cash Flow	-15.16	-22.76	-9.11	-8.81	-6.71	Upgrade
Acquisitions	0	-2.37	0	0	0	Upgrade
Change in Investments	0	0	0	0	2.36	Upgrade
Investing Cash Flow	0	-2.37	0	0	2.36	Upgrade
Share Issuance / Repurchase	12.97	3.73	28.11	12.14	3.82	Upgrade
Financing Cash Flow	12.97	3.73	28.11	12.14	3.82	Upgrade
Exchange Rate Effect	0.06	1.18	-0.18	0	0.02	Upgrade
Net Cash Flow	-2.18	-21.4	19	3.33	-0.54	Upgrade
Free Cash Flow	-15.16	-22.76	-9.11	-8.81	-6.71	Upgrade
Free Cash Flow Margin	-65895.65%	-84303.70%	-59.83%	-830.35%	-429.01%	Upgrade
Free Cash Flow Per Share	-0.93	-1.72	-0.96	-1.42	-1.39	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).